Sistema de Salut de Catalunya
Wilzeck, Verena Charlotte
Mandoli, Giulia Elena
Demirkiran, Ahmet
Androulakis, Emmanuel
Soliman Aboumarie, Hatem
Giannopoulos, Andreas
Rodríguez Palomares, José F
Institut Català de la Salut
[Wilzeck VC] Department of Cardiology, University Heart Center, University Hospital Zurich, Zürich, Switzerland. Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zürich, Switzerland. Institute for Biomedical Engineering, University and ETH Zurich, Zürich, Switzerland. [Mandoli GE] Department of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy. [Demirkiran A] Department of Cardiology, Amsterdam UMC, Amsterdam, The Netherlands. Department of Cardiology, Kocaeli City Hospital, Kocaeli, Türkiye. [Androulakis E] King’s College Hospital, London NHS Foundation Trust, London, UK. School of Cardiovascular and Metabolic Medicine & Sciences, King’s College London, London, UK. [Soliman Aboumarie H] School of Cardiovascular and Metabolic Medicine & Sciences, King’s College London, London, UK. Department of Cardiothoracic Anaethesia, Intensive Care and Mechanical Circulatory Support, Harefield Hospital, Royal Brompton and Harefield Hospitals, London, UK. [Giannopoulos AA] Department of Nuclear Medicine, Cardiac Imaging, University Hospital Zurich, Zürich, Switzerland. [Palomares JF] Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca de Malalties Cardiovasculars, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. CIBER de Enfermedades Cardiovasculares, Instituto de Salud Carlos III, Madrid, Spain
Vall d'Hebron Barcelona Hospital Campus
2025-11-07T11:37:39Z
2025-11-07T11:37:39Z
2025-07
Cardiac computed tomography angiography; Cardiovascular magnetic resonance; Coronary artery disease
Angiografia per tomografia computada cardíaca; Ressonància magnètica cardiovascular; Malalties de les artèries coronàries
Angiografía por tomografía computarizada cardíaca; Resonancia magnética cardiovascular; Enfermedades de las arterias coronarias
Aims To evaluate the current role and practice patterns in myocardial viability assessment through a European Association of Cardiovascular Imaging (EACVI) survey. Methods and results A total of 179 participants from 54 countries completed the survey. Most participants worked in tertiary centres (60.3%). Transthoracic echocardiography (TTE) was the most widely available modality (98.3%), followed by stress echocardiography (86.6%), cardiac computed tomography angiography (87.7%), and cardiovascular magnetic resonance (CMR, 84.9%). Single-photon emission computed tomography and positron emission tomography were less accessible (59.8 and 40.2%, respectively). CMR was the preferred imaging modality (76.0%), followed by TTE (41.9%), which were also the most frequently used techniques in clinical practice (42.7 and 38.7%, respectively). Viability imaging was regularly used by most respondents in patients with chronic ischaemic heart disease (57.0%) and prior to revascularization for chronic total occlusions (58.7%). Among late-presenting ST-elevation myocardial infarction patients, 60.7% of respondents assessed viability within index hospitalization or the first month, whereas 28.3% performed viability imaging after 1–3 months. However, considerable variation exists between respondents. Revascularization decisions were guided by viability findings with revascularization of only viable segments in 49.1% of cases, while 40.0% reported revascularizing all high-grade stenoses if any viable myocardium was present. Conclusion This study highlights the variability in myocardial viability imaging practices across Europe, with differences in availability, preferred modalities, and clinical application. While CMR and TTE remain the dominant modalities, standardization of imaging protocols and further research are needed to optimize viability assessment and its impact on revascularization decisions.
English
Enquestes; Cor - Imatgeria; Malalties coronàries - Imatgeria; Miocardi - Imatgeria; ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Epidemiologic Methods::Data Collection::Surveys and Questionnaires; DISEASES::Cardiovascular Diseases::Heart Diseases::Myocardial Ischemia::Coronary Disease::Coronary Artery Disease; ANATOMY::Cardiovascular System::Heart::Myocardium; ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Diagnostic Techniques and Procedures::Diagnostic Imaging::Cardiac Imaging Techniques; DISEASES::Cardiovascular Diseases::Heart Diseases::Myocardial Ischemia::Coronary Disease; TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::métodos epidemiológicos::recopilación de datos::encuestas y cuestionarios; ENFERMEDADES::enfermedades cardiovasculares::enfermedades cardíacas::isquemia miocárdica::enfermedad coronaria::enfermedad arterial coronaria; ANATOMÍA::sistema cardiovascular::corazón::miocardio; ENFERMEDADES::enfermedades cardiovasculares::enfermedades cardíacas::isquemia miocárdica::enfermedad coronaria; TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::técnicas y procedimientos diagnósticos::diagnóstico por imagen::técnicas de imagen cardíaca
Oxford University Press
European Heart Journal - Imaging Methods and Practice;3(2)
https://doi.org/10.1093/ehjimp/qyaf095
Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
Articles científics - HVH [3375]
Articles científics - VHIR [1654]
